Evidence map›Paper›PMID 35663790›Full record

ArticleInternational journal of pediatrics & adolescent medicine2022

Epidemiology, clinical features, and outcomes of coronavirus disease among children in Al-Madinah, Saudi Arabia: A retrospective study.

Amer Alshengeti, Hatem Alahmadi, Ashwaq Barnawi, Nouf Alfuraydi, Abdulsalam Alawfi, Arwa Al-Ahmadi, Mohammad Sheikh, Amani Almaghthawi, Zahera Alnakhli, Raghad Rasheed and 4 more

Abstract read
In one paragraph

Article in International journal of pediatrics & adolescent medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Ferritin in pediatric critical illness: a scoping review.Clinical and experimental pediatrics · 2023
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Amer AlshengetiDepartment of Pediatrics, College of Medicine, Taibah University, Al-Madinah, Saudi Arabia.
Hatem AlahmadiInfectious Disease Division, Department of Pediatrics, Madinah Maternity and Children Hospital, Al-Madinah, Saudi Arabia.
Ashwaq BarnawiInfectious Disease Division, Department of Pediatrics, Madinah Maternity and Children Hospital, Al-Madinah, Saudi Arabia.
Nouf AlfuraydiInfectious Disease Division, Department of Pediatrics, Madinah Maternity and Children Hospital, Al-Madinah, Saudi Arabia.
Abdulsalam AlawfiDepartment of Pediatrics, College of Medicine, Taibah University, Al-Madinah, Saudi Arabia.
Arwa Al-AhmadiDepartment of Pediatrics, Madinah Maternity and Children Hospital, Al-Madinah, Saudi Arabia.
Mohammad SheikhDepartment of Pediatrics, Madinah Maternity and Children Hospital, Al-Madinah, Saudi Arabia.
Amani AlmaghthawiDepartment of Pediatrics, Madinah Maternity and Children Hospital, Al-Madinah, Saudi Arabia.
Zahera AlnakhliDepartment of Pediatrics, Madinah Maternity and Children Hospital, Al-Madinah, Saudi Arabia.
Raghad RasheedDepartment of Pediatrics, Madinah Maternity and Children Hospital, Al-Madinah, Saudi Arabia.
Amany IbrahimDepartment of Pediatrics, Saudi German Hospital, Al-Madinah, Saudi Arabia.
Ahmed SobhiDepartment of Pediatrics, Saudi German Hospital, Al-Madinah, Saudi Arabia.
Dayel Al ShahraniChildren's Hospital, King Fahad Medical City, Riyadh, Saudi Arabia.
Faisal KordyInfectious Disease Division, Department of Pediatrics, Madinah Maternity and Children Hospital, Al-Madinah, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objective: Coronavirus disease (COVID-19) is milder with favorable outcomes in children than in adults. However, detailed data regarding COVID-19 in children from Saudi Arabia are scarce. This study aimed to describe COVID-19 among children in Al-Madinah, Saudi Arabia. Methods: This retrospective observational study included children <14 years old hospitalized with COVID-19 between May 1, 2020 and July 31, 2020. Clinical data, COVID-19 disease severity, and outcomes were collected. The total number of presenting symptoms and signs were computed by counting those recorded upon presentation. The Kruskal-Wallis non-parametric test was used to compare the number of symptoms and signs across all levels of COVID-19 severity. Result: Overall, 106 patients met the inclusion criteria; their ages ranged from 2 weeks to 13 years. Most patients were ≤12 months of age (43.4%). Bronchial asthma was the most common comorbidity (9.4%). Among 99 symptomatic patients, fever was the most common symptom (84.8%); seven patients (7%) were diagnosed with febrile seizure. Most COVID-19 cases were mild (84%); one patient (0.94%) was in critical condition and one patient (0.94%) met the Multisystem Inflammatory Syndrome in children criteria. The mean number of symptoms and signs in children with severe or critical COVID-19 was significantly higher than that in children with mild cases or non-severe pneumonia ( Conclusions: COVID-19 mortality in children is rare; however, while most children exhibit mild disease with favorable outcomes, children with chronic lung disease may be at higher risk for severe disease.

Indexed as

ChildrenCoronavirusFebrile seizureSARS-CoV-2Saudi Arabia

Identifiers

PMID35663790
PMCPMC9152574

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.